1. Short title This Act may be cited as the Ovarian, Cervical, and Endometrial Cancer Awareness Act of 2023 . 2. Findings The Congress finds as follows: (1) Ovarian cervical cancers are among the most destructive gynecological forms of cancer. (2) Ovarian cancer causes more deaths than any other cancer of the female reproductive system. (3) Currently there is no effective way to screen for ovarian or endometrial cancer. (4) The main method used to screen for cervical cancer is the Pap test which does not identify other gynecologic cancers. (5) Most women who develop invasive cervical cancer have not had regular cervical cancer screening. (6) Black women are more likely to die from endometrial cancer. Compared to White women, Black patients have an 80-percent higher mortality rate. (7) In 2018, Hispanic women had the highest endometrial cancer rate among young reproductive-age women ages 35 to 39, a rate 50 percent higher than that of White women. 3. Purposes The purposes of this Act are the following: (1) Raising awareness about ovarian, endometrial, and cervical cancers. (2) Raising awareness about the importance of knowing one’s hereditary risk of developing cancer, including the understanding of family history and the role of genetic testing and counseling. (3) Raising awareness about the importance of screening for cervical cancer. (4) Promotion of the potential value of risk-reducing interventions for ovarian, endometrial, and cervical cancer. (5) Ensuring that special emphasis is given to ovarian, cervical, and endometrial cancer under the public awareness campaign carried out by the Secretary of Health and Human Services under section 317P(d) of the Public Health Service Act ( 42 U.S.C. 247b–17(d) ; commonly referred to as Johanna’s Law ). 4. Increasing public awareness of ovarian, cervical, and endometrial cancer Section 317P(d) of the Public Health Service Act ( 42 U.S.C. 247b–17(d)